← FDA Drug Approvals (Drugs@FDA)
OSMOPREP
NDA · New Drug Application · Sponsor: SALIX PHARMS · Approved 2006-03-16
Drug application
- FDA Application #
NDA021892- Application type
- New Drug Application
- Brand name
- OSMOPREP
- Generic name
- Sodium Phosphate, Dibasic, Anhydrous
- Active ingredients
- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- SALIX PHARMS
- First approval
- 2006-03-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown